CMO Troy achieves quest for brand ownership

Contractor Troy Manufacturing, after 20 years of making the topical analgesic pain reliever Stopain for DRJ Group, will now begin marketing it. Troy has bought the rights to the drug, thereby fulfilling its ambition. "If we had to be a contract manufacturer first, then so be it," says VP Anthony Cicini, in a local press report, "Getting out of the contract manufacturing business was by design, not by circumstance." Story

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.